Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

Market Cap	4.46B +25.6%
Revenue (ttm)	1.55B +0.4%
Net Income	162.24M -3.7%
EPS	0.86 -2.2%
Shares Out	190.18M
PE Ratio	27.25
Forward PE	n/a
Dividend	0.50 (2.13%)
Ex-Dividend Date	Nov 28, 2025

Volume	2,379,360
Average Volume	1,714,015
Open	23.33
Previous Close	23.45
Day's Range	22.60 - 23.45
52-Week Range	21.46 - 41.47
Beta	0.03
RSI	46.77
Earnings Date	Apr 28, 2026

About SHE:003020

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA. It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 1,456
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 003020

Financial Performance

In 2025, SHE:003020's revenue was 1.55 billion, an increase of 2.33% compared to the previous year's 1.52 billion. Earnings were 165.20 million, an increase of 2.86%.